The World Orphan Drug Congress (WODC) 2025 is the premier global event dedicated to advancing the development and delivery of treatments for rare diseases. Bringing together industry leaders, researchers, policymakers, patient advocates, and biotech innovators, this conference serves as a vital platform for driving progress in orphan drug development, regulatory frameworks, and patient access.
With a diverse agenda covering drug repurposing, gene therapy, market access, pricing, and patient-centric solutions, the event fosters collaboration and knowledge-sharing to accelerate breakthroughs in rare disease treatment. Attendees can expect engaging keynote presentations, panel discussions, networking opportunities, and an exhibition showcasing cutting-edge advancements in the field.
ERN members and Patient organizations have the possibility to get free tickets by selecting “Free tickets for Patient Groups” and completing the form (the label says Patient groups but the page mentions “The following guest form is intended for patient group organisations, ERNs, charities, public health officials , and individuals working at selected pharmaceuticals/biotechs” and we received confirmation that ERN members are entitled to free tickets)
The agenda is accessible here: https://www.terrapinn.com/conference/world-orphan-drug-congress/Agenda.stm